Similar results have been shown for other mAbs anti-EGFR such as: cetuximab using HNSCC cells and trastuzumab in breast carcinoma bearing-mice (Wolpoe et al., 2003; Srivastava et al., 2013). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.